A. Samaan, The antagonistic cardiac nerves and heart rate, J. Physiol, vol.83, issue.3, pp.332-340, 1935.

M. N. Levy and H. Zieske, Autonomic control of cardiac pacemaker activity and atrioventricular transmission, J. Appl. Physiol, vol.27, issue.4, pp.465-470, 1969.

M. N. Levy, Vagus nerve stimulation inhibits the increase in Ca2+ transient and left ventricular force caused by sympathetic nerve stimulation but has no direct effects alone-epicardial Ca2+ fluorescence studies using fura-2AM in the isolated innervated beating rab, Exp. Physiol, vol.19, issue.1, pp.80-92, 1966.

B. S. Kolman, R. L. Verrier, and B. Lown, The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions, Circulation, vol.52, issue.4, pp.578-585, 1975.

S. H. Rabinowitz, R. L. Verrier, and B. Lown, Muscarinic effects of vagosympathetic trunk stimulation on the repetitive extrasystole (RE) threshold, Circulation, vol.53, issue.4, pp.622-627, 1976.

M. S. Yoon, Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles, Am. Heart J, vol.93, issue.1, pp.60-65, 1977.

E. Muscholl, Peripheral muscarinic control of norepinephrine release in the cardiovascular system, Am. J. Physiol, vol.239, issue.6, pp.713-720, 1980.

E. K. Potter and L. G. Ulman, Neuropeptides in sympathetic nerves affect vagal regulation of the heart, News Physiol. Sci, vol.9, pp.174-177, 1994.

N. Herring, Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway, J. Mol. Cell. Cardiol, vol.44, issue.3, pp.477-485, 2008.

D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman et al.,

J. Mcgregor, K. Metra, M. Morais, J. Osterspey, A. Tamargo et al., American College of Cardiology/American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association & Heart Rhythm Society

A. Esc, Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the, European Heart Rhythm Association and the Heart Rhythm Society, 2006.

G. I. Fishman, S. S. Chugh, J. P. Dimarco, C. M. Albert, M. E. Anderson et al., Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop, Circulation, vol.122, issue.22, pp.2335-2348, 2010.

R. Deo and C. M. Albert, Epidemiology and genetics of sudden cardiac death, Circulation, vol.125, issue.4, pp.620-637, 2012.

L. Bayes, Ambulatory sudden cardiac death. Mecanisms of production of fatal arrhythmia on the basis of data from 157 cases, Am Heart J, vol.117, pp.151-159, 1989.

A. S. Adabag, R. V. Luepker, V. L. Roger, and B. J. Gersh, Sudden cardiac death: epidemiologic and risk factors, Nat Rev Cardiol, vol.7, pp.216-225, 2010.

N. A. Estes, Predicting and preventing sudden cardiac death, Circulation, vol.124, issue.5, pp.651-656, 2011.

Z. Zheng, J. B. Croft, W. H. Giles, and G. A. Mensah, Sudden Cardiac Death in the United States, Circulation, vol.104, issue.18, pp.2158-63, 1989.

S. S. Chugh, A. Uy-evanado, C. Teodorescu, K. Reinier, R. Mariani et al., Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: The Ore-SUDS (Oregon Sudden Unexpected Death Study), J Am Coll Cardiol, vol.54, issue.22, pp.2006-2011, 2009.

. Myerburg, M. J. Junttila, C. Napolitano, R. Bloise, N. Monteforte et al., Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation, Circulation, vol.125, issue.8, pp.2027-2034, 2012.

L. A. Cupples, D. Gagnon, and W. B. Kannel, Long-and short-term risk of sudden coronary death, Circulation, vol.85, issue.1, pp.11-19, 1992.

W. G. Stevenson, L. W. Stevenson, H. Middlekauff, and L. A. Saxon, Sudden death prevention in patients with advanced ventricular dysfunction, Circulation, vol.88, issue.6, pp.2953-2961, 1993.

J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight et al., American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death, American College of Cardiology Foundation & Heart Rhythm Society, 2008.

, American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation, vol.118, issue.14, pp.1497-1518

A. H. Villuendas-r-&-kadish, Z. J. Zheng, J. B. Croft, W. Giles, and G. A. Mensah, Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed, Prog Cardiovasc Dis, vol.51, issue.2, pp.2158-2163, 1989.

K. M. Stein, Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration, Prog Cardiovasc Dis, vol.51, issue.2, pp.106-117, 2008.

A. E. Epstein, J. P. Dimarco, K. A. Ellenbogen, N. A. Estes, R. A. Freedman et al.,

. Cardiology/american, Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE

A. Hrs, Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons, Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices), American Association for Thoracic Surgery & Society of Thoracic Surgeons, vol.117, pp.2109-2118, 2008.

X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere, Predicting sudden death in the population: the Paris Prospective Study I, Circulation, vol.99, pp.1978-1983, 1999.

Y. Friedlander, D. S. Siscovick, S. Weinmann, M. A. Austin, B. M. Psaty et al., Family history as a risk factor for primary cardiac arrest, Circulation, vol.97, pp.155-160, 1998.

L. R. Dekker, C. R. Bezzina, J. P. Henriques, M. W. Tanck, K. T. Koch et al., Familial sudden death is an important risk factor for primary ventricular fibrillation: a casecontrol study in acute myocardial infarction patients, Circulation, vol.114, pp.1140-1145, 2006.

K. S. Kaikkonen, M. L. Kortelainen, E. Linna, and H. V. Huikuri, Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event, Circulation, vol.114, pp.1462-1467, 2006.

C. Newton-cheh, M. G. Larson, D. C. Corey, E. J. Benjamin, A. G. Herbert et al., QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: the Framingham Heart Study, Heart Rhythm, vol.2, pp.277-284, 2005.

P. S. Chan, J. D. Birkmeyer, H. M. Krumholz, J. A. Spertus, and B. K. Nallamothu, Racial and gender trends in the use of implantable cardioverterdefibrillators among Medicare beneficiaries between, Congest Heart Fail, vol.15, pp.51-57, 1997.

C. Teodorescu, K. Reinier, C. Dervan, A. Uy-evanado, M. Samara et al., Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon Sudden Unexpected Death Study, Circulation, vol.122, pp.2116-2122, 2010.

P. S. Chan, G. Nichol, H. M. Krumholz, J. A. Spertus, P. G. Jones et al., Racial differences in survival after in-hospital cardiac arrest, JAMA, vol.302, pp.1195-1201, 2009.

L. J. Martin, A. G. Comuzzie, G. E. Sonnenberg, J. Myklebust, R. James et al., Major quantitative trait locus for resting heart rate maps to a region on chromosome 4, Hypertension, vol.43, pp.1146-1151, 2004.

R. Manfredini, F. Portaluppi, E. Grandi, C. Fersini, and M. Gallerani, Out-of hospital sudden death referring to an emergency department, J Clin Epidemiol, vol.49, pp.865-868, 1996.

G. , Neuro-cardiac interaction in malignant ventricular arrhythmia and sudden cardiac death, Autonomic Neuroscience: Basic and Clinical, vol.199, pp.66-79, 2016.

M. J. Shen and D. P. Zipes, Role of the autonomic nervous system in modulating cardiac arrhythmias, Circ. Res, vol.114, issue.6, pp.1004-1021, 2014.

S. Oppenheimer, Cerebrogenic cardiac arrhythmias: cortical lateralization and clinical significance, Clin. Auton. Res, vol.16, issue.1, pp.6-11, 2006.

P. Taggart, Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population, Front. Physiol, vol.2, issue.10, pp.801-806, 1987.

J. Nolan, Prospective study of heart rate variability and mortality in chronic heart failure-results of the United Kingdom heart failure evaluation and assessment of risk trial, Circulation, vol.98, issue.15, pp.1510-1516, 1998.

M. T. La-rovere, Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction, Lancet, vol.351, pp.478-484, 1998.

P. J. Schwartz, The autonomic nervous system and sudden death, Eur. Heart J, vol.19, pp.72-80, 1998.

R. L. Verrier, P. L. Thompson, and B. Lown, Ventricular vulnerability during sympathetic stimulation: role of heart rate and blood pressure, Cardiovasc. Res, vol.8, pp.602-610, 1974.

G. W. Parker, Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs, 48-Einbrodt, 1859. Ueber Herzeizung und ihr Verhaeltnis zum Blutdruck. Akad. Wiss. Sitzungsber, vol.66, pp.345-359, 1990.

E. Vanoli, Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction, 1991.

, Circ. Res, vol.68, pp.1471-1481

P. J. Schwartz and D. P. Zipes, Autonomic modulation of cardiac arrhythmias and sudden cardiac death, Cardiac Electrophysiology: From Cell to Bedside, 1988.

B. S. Kolman, R. L. Verrier, and B. Lown, The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of the sympathetic parasympathetic interactions, Circulation, vol.52, pp.578-585, 1976.

M. N. Levy, Neural control of cardiac function, Baillieres Clin. Neurol, vol.6, pp.227-244, 1997.

J. B. Martins and D. P. Zipes, Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle, Circ. Res, vol.46, issue.1, pp.100-110, 1980.

P. G. Volders, Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation, Circulation, vol.107, pp.2753-2760, 2003.

A. Dahlström, Observations on adrenergic innervation of dog heart, Am. J. Physiol, vol.209, issue.4, pp.689-692, 1965.

H. Kawano, R. Okada, and K. Yano, Histological study on the distribution of autonomic nerves in the human heart, Heart Vessels, vol.18, issue.1, pp.32-39, 2003.

G. A. Ng, Sympathetic nerve stimulation produces spatial heterogeneities of action potential restitution, Heart Rhythm, vol.6, issue.5, pp.696-706, 2009.

J. J. Kammerling, Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction, Circulation, vol.76, issue.2, pp.383-393, 1987.

J. M. Cao, Relationship between regional cardiac hyperinnervation and ventricular arrhythmia, Circulation, vol.101, issue.16, pp.1960-1969, 2000.

S. Zhou, Mechanisms of cardiac nerve sprouting aftermyocardial infarction in dogs, Circ. Res, vol.95, issue.1, pp.76-83, 2004.

S. Han, Electroanatomic remodeling of the left stellate ganglion after myocardial infarction, J. Am. Coll. Cardiol, vol.59, issue.10, pp.954-961, 2012.

O. A. Ajijola, Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: neuropeptide and morphologic changes, Heart Rhythm, vol.12, issue.5, pp.1027-1035, 2015.

P. S. 63-rajendran, Myocardial infarction induces structural and functional remodeling of the intrinsic cardiac nervous system, J. Physiol, vol.2, pp.321-341, 2016.

J. N. Weiss, Ventricular fibrillation: how do we stop thewaves frombreaking?, Circ. Res, vol.87, pp.1103-1107, 2000.
DOI : 10.1161/01.res.87.12.1103
URL : https://www.ahajournals.org/doi/pdf/10.1161/01.RES.87.12.1103

A. Karma, Spiral breakup inmodel equations of action potential propagation in cardiac tissue, Phys. Rev. Lett, vol.71, issue.7, pp.1103-1106, 1993.

M. L. Riccio, M. L. Koller, and R. F. Gilmour, Electrical restitution and spatiotemporal organization during ventricular fibrillation, Circ. Res, vol.84, issue.8, pp.955-963, 1999.
DOI : 10.1161/01.res.84.8.955
URL : http://circres.ahajournals.org/content/84/8/955.full.pdf

A. Garfinkel, Preventing ventricular fibrillation by flattening cardiac restitution, Proc. Natl. Acad. Sci. U. S. A, vol.97, issue.11, pp.6061-6066, 2000.
DOI : 10.1073/pnas.090492697
URL : http://www.pnas.org/content/97/11/6061.full.pdf

J. H. Coote, Myths and realities of the cardiac vagus, J. Physiol, vol.591, pp.4073-4085, 2013.

O. E. Brodde, Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart, Basic Res. Cardiol, vol.96, issue.6, pp.528-538, 2001.

B. J. Scherlag, Electrophysiology underlying ventricular arrhythmias due to coronary ligation, Am. J. Physiol, vol.219, issue.6, pp.1665-1671, 1970.
DOI : 10.1152/ajplegacy.1970.219.6.1665

R. E. Goldstein, Influence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs, Circulation, vol.47, issue.6, pp.1180-1190, 1973.

P. B. Corr and R. A. Gillis, Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion, Circulation, vol.49, issue.1, pp.86-97, 1974.

G. Zuanetti, Protective effect of vagal stimulation on reperfusion arrhythmias in cats, Circ. Res, vol.61, issue.3, pp.429-435, 1987.

B. Olshansky, Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy, Circulation, vol.118, issue.8, pp.863-871, 2008.
DOI : 10.1007/978-3-319-15961-4_6

K. E. Brack, J. Winter, and G. A. Ng, Mechanisms underlying the autonomicmodulation of ventricular fibrillation initiationtentative prophylactic properties of vagus nerve stimulation onmalignant arrhythmias in heart failure, Heart Fail. Rev, vol.18, issue.4, pp.389-408, 2013.

D. Ferrari, G. M. Vanoli, E. Stramba-badiale, and M. , Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction, Circ Res, vol.68, issue.5, pp.1471-1481, 1991.

D. Ferrari, G. M. Vanoli, E. Curcuruto, and P. , Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine, Am Heart J, vol.124, issue.4, p.1382385, 1992.

P. Chevalier, F. Ruffy, and P. Danilo, Interaction between alpha-1 adrenergic and vagal effects on cardiac rate and repolarization

, J Pharmacol Exp Ther, vol.284, issue.3, p.9495840, 1998.

T. Kawada, T. Yamazaki, and T. Akiyama, Differential acetylcholine release mechanisms in the ischemic and non-ischemic myocardium, J Mol Cell Cardiol, vol.32, issue.3, p.10731440, 2000.
DOI : 10.1006/jmcc.1999.1087

J. F. Aupetit, D. Frassati, and B. Bui-xuan, Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration, Cardiovasc Res, vol.37, issue.3, p.9659448, 1998.

M. Ando, R. G. Katare, and Y. Kakinuma, Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein, Circulation, vol.112, issue.2, p.15998674, 2005.
DOI : 10.1161/circulationaha.104.525493
URL : https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.104.525493

W. Manati, J. Pineau, R. D. Puertas, E. Morel, T. Quadiri et al., The antiarrhythmic effect of vagal stimulation after acute coronary occlusion: Role of the heart rate, Cardiologie Journal, 2017.

J. F. Aupetit, D. Frassati, and B. Bui-xuan, Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration, Cardiovasc Res, vol.37, issue.3, p.9659448, 1998.

J. F. Aupetit, B. Bui-xuan, and I. Kioueh, Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization, Can J Physiol Pharmacol, vol.78, issue.3, p.10721812, 2000.

F. Vaillant, J. Descotes, and A. Tabib, Protective effect of ivabradine against ventricular fibrillation in pigs during acute myocardial ischemia

, Acetylcholine causes coronary vasodilation in dogs and baboons, Eur Heart J, vol.65, issue.6, p.2582591, 1989.

V. Fuster, L. Badimon, J. J. Badimon, and J. H. Chesebro, The pathogenesis of coronary artery disease and the acute coronary syndromes

, N Engl J Med, vol.326, pp.310-318, 1992.

T. Furukawa, K. Moroe, H. N. Mayrovitz, R. Sampsell, N. Furukawa et al., Arrhythmogenic effects of graded coronary blood flow reductions superimposed on prior myocardial infarction in dogs, Circulation, vol.84, pp.368-377, 1991.

D. Mehta, J. Curwin, J. A. Gomes, and V. Fuster, Sudden death in coronary artery disease: acute ischemia versus myocardial substrate, Circulation, vol.96, pp.3215-3223, 1997.

J. A. Goldstein, D. Demetriou, C. L. Grines, M. Pica, M. Shoukfeh et al., Multiple complex coronary plaques in patients with acute myocardial infarction, N Engl J Med, vol.343, pp.915-922, 2000.

A. T. Yan, A. J. Shayne, K. A. Brown, S. N. Gupta, C. W. Chan et al., Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality, Circulation, vol.114, pp.32-39, 2006.

A. Schmidt, C. F. Azevedo, A. Cheng, S. N. Gupta, D. A. Bluemke et al.,

J. A. Wu and K. C. , Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction, Circulation, vol.115, pp.2006-2014, 2007.

S. Tamaki, T. Yamada, Y. Okuyama, T. Morita, S. Sanada et al.,

M. Fukunami, Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic function: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion, J Am Coll Cardiol, vol.53, pp.426-435, 2009.

R. J. Goldberg, J. Yarzebski, F. A. Spencer, J. C. Zevallos, D. Lessard et al., Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation, Am J Cardiol, vol.102, pp.1595-1601, 2008.

A. T. Askari, M. H. Shishehbor, M. A. Kaminski, M. J. Riley, A. Hsu et al., The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: insights from Global Use of Strategies to Open Coronary Arteries (GUSTO) V, Am Heart J, vol.158, pp.238-243, 2009.

D. G. Wyse, P. L. Friedman, M. A. Brodsky, K. J. Beckman, M. D. Carlson et al.,

, Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up, AVID Investigators

, J Am Coll Cardiol, vol.38, pp.1718-1724, 2001.

R. J. Myerburg, V. Reddy, and A. Castellanos, Indications for implantable cardioverter-defibrillators based on evidence and judgment, J Am Coll Cardiol, vol.54, pp.747-763, 2009.

M. E. Josephson, Recurrent Ventricular Tachycardia, Anonymous Clinical Cardiac electrophysiology: Techniques and Interpretation, pp.446-642, 2008.

D. P. Rubart-m-&-zipes, Genesis of Cardiac Arrhythmias: Electrophysiological Considerations, 2008.

, Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, pp.727-762

E. D. Engelstein and D. P. Zipes, Sudden cardiac death, The Heart, Arteries and Veins, pp.1081-1112, 1998.

R. J. Myerburg and A. Castellanos, Heart Disease: A Textbook of Cardiovascular Medicine, vol.1997, pp.742-779

L. Fei, A. Baron, D. P. Henry, and D. P. Zipes, Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties, Circulation, vol.96, pp.4044-4049, 1997.

L. M. Owens, T. A. Fralix, E. Murphy, W. E. Cascio, and L. S. Gettes, Correlation of ischemia-induced extracellular and intracellular ion changes to cellto-cell electrical uncoupling in isolated blood-perfused rabbit hearts, Circulation, vol.94, pp.10-13, 1996.

T. Satoh and D. P. Zipes, Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation

, J Cardiovasc Electrophysiol, vol.7, pp.833-842, 1996.

C. R. Bezzina, R. Pazoki, and A. Bardai, Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction, Nat Genet, vol.42, pp.688-691, 2010.

W. Bodmer and C. Bonilla, Common and rare variants in multifactorial susceptibility to common diseases, Nat Genet, vol.40, pp.695-701, 2008.

C. M. Albert, C. A. Macrae, and D. I. Chasman, Common variants in cardiac ion channel genes are associated with sudden cardiac death, Circ Arrhythm Electrophysiol, vol.3, pp.222-229, 2010.

S. K. Westaway, K. Reinier, and A. Huertas-vazquez, Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease, Circ Cardiovasc Genet, vol.4, pp.397-402, 2011.

E. C. Stecker, M. Sono, and E. Wallace, Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease, Heart Rhythm, vol.3, pp.697-700, 2006.

A. Burke, W. Creighton, and E. Mont, Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks, Circulation, vol.112, pp.798-802, 2005.

I. Splawski, K. W. Timothy, and M. Tateyama, Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia, Science, vol.297, pp.1333-1336, 2002.

C. M. Albert, E. G. Nam, and E. B. Rimm, Cardiac sodium channel gene variants and sudden cardiac death in women, Circulation, vol.117, pp.16-23, 2008.

L. Crotti, D. Hu, and H. Barajas-martinez, Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant, Heart Rhythm, vol.9, pp.1104-1112, 2012.

D. E. Arking, A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization, Nat Genet, vol.38, pp.644-651, 2006.

D. E. Arking, K. Reinier, and W. Post, Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest, PloS One, vol.5, p.9879, 2010.

B. E. Aouizerat, E. Vittinghoff, and S. L. Musone, GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease, BMC Cardiovasc Disord, vol.11, p.29, 2011.

D. E. Arking, M. J. Junttila, and P. Goyette, Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genomewide association in European ancestry individuals, PLoS Genet, vol.7, p.1002158, 2011.

M. Eijgelsheim, Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study, Hum Mol Genet, vol.18, pp.4213-4218, 2009.

W. H. Kao, Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations, Circulation, vol.119, pp.940-951, 2009.

A. M. Lahtinen, P. A. Noseworthy, and A. S. Havulinna, Common genetic variants associated with sudden cardiac death: the FinSCDgen study, PloS One, vol.7, p.41675, 2012.
DOI : 10.1371/journal.pone.0041675
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0041675&type=printable

C. Newton-cheh, N. R. Cook, and M. Vandenburgh, A common variant at 9p21 is associated with sudden and arrhythmic cardiac death, Circulation, vol.120, pp.2062-2068, 2009.
DOI : 10.1161/circulationaha.109.879049
URL : https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.109.879049

J. Chen, X. Xie, and J. Zhu, Single-nucleotide polymorphisms in SCN5A gene in Chinese Han population and their correlation with cardiac arrhythmias, Genet Med, vol.6, p.159, 2004.
DOI : 10.1097/00125817-200405000-00009
URL : https://www.nature.com/articles/gim200432.pdf

M. K. Son, C. Ki, and S. Park, Genetic mutation in Korean patients of sudden cardiac arrest as a surrogating marker of idiopathic ventricular arrhythmia, J Korean Med Sci, vol.28, pp.1021-1026, 2013.

A. Huertas-vazquez, C. P. Nelson, and X. Guo, Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease, PloS One, vol.8, p.59905, 2013.

M. C. Gavin, C. Newton-cheh, and J. M. Gaziano, A common variant in the 2-adrenergic receptor and risk of sudden cardiac death, Heart Rhythm, vol.8, pp.704-710, 2011.

N. Sotoodehnia, D. S. Siscovick, and M. Vatta, Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death, Circulation, vol.113, pp.1842-1848, 2006.

Z. H. Tseng, Genetic association studies of sudden cardiac death/arrest: the importance of context, Heart Rhythm, vol.6, pp.1315-1317, 2009.

Z. H. Tseng, B. E. Aouizerat, and L. Pawlikowska, Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease, Heart Rhythm, vol.5, pp.814-821, 2008.

M. M. Refaat, B. E. Aouizerat, and C. R. Pullinger, Association ofCASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease, Heart Rhythm, vol.11, pp.646-652, 2014.

B. Marcsa, R. Dénes, and K. Vörös, A common polymorphism of the human cardiac sodium channel alpha subunit (SCN5A) gene is associated with sudden cardiac death in chronic ischemic heart disease, PloS One, vol.10, p.132137, 2015.

R. Jabbari, L. R. Dekker, C. R. Bezzina, J. P. Henriques, M. W. Tanck et al., Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients, pii: B5246 127, vol.63, pp.1134-1140, 2006.

X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere, Predicting sudden death in the population : the Paris Prospective study I, Circulation, vol.99, issue.15, pp.1978-83, 1999.

D. A. Tregouet, V. Garelle, N. Tahri-daizadeh, D. A. Tregouet, V. Nicaud et al., Automated Detection of Informative Combined Effects in Genetic Association Studies of Complex Traits, A new JAVA implementation of THESIAS: Testing Haplotype EffectS In Association Studies. Bioinformatics 2007 in press 130, pp.1952-1960, 2003.

N. E. Breslow, N. Day, S. K. Westaway, K. Reinier, A. Huertas-vazquez et al., Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease, Statistical methods in cancer research, vol.1, pp.397-402, 1980.

C. M. Albert, C. A. Macrae, D. I. Chasman, M. Vandenburgh, J. E. Buring et al., Common variants in cardiac ion channel genes are associated with sudden cardiac death, Circ Arrhythm Electrophysiol, vol.3, pp.222-229, 2010.

A. Burke, W. Creighton, E. Mont, L. Li, S. Hogan et al., Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks, Circulation, vol.112, pp.798-802, 2005.

I. Splawski, K. W. Timothy, M. Tateyama, C. E. Clancy, A. Malhotra et al., Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia, Science, vol.297, pp.1333-1336, 2002.

M. C. Gavin, C. Newton-cheh, J. M. Gaziano, N. R. Cook, M. Vandenburgh et al., A common variant in the beta2-adrenergic receptor and risk of sudden cardiac death, Heart Rhythm, vol.8, pp.704-710, 2011.

Z. H. Tseng, B. E. Aouizerat, L. Pawlikowska, E. Vittinghoff, F. Lin et al., Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease, Heart Rhythm, vol.5, pp.814-821, 2008.

N. Sotoodehnia, D. S. Siscovick, M. Vatta, B. M. Psaty, R. P. Tracy et al., Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death, Circulation, vol.113, pp.1842-1848, 2006.

N. Sotoodehnia, G. Li, C. O. Johnson, R. N. Lemaitre, K. M. Rice et al., Genetic variation in angiotensin-converting enzymerelated pathways associated with sudden cardiac arrest risk, Heart Rhythm, vol.6, pp.1306-1314, 2009.

A. Y. Sun, J. I. Koontz, S. H. Shah, J. P. Piccini, K. R. Nilsson et al., The S1103Y cardiac sodium channel variant is associated with implantable cardioverterdefibrillator events in blacks with heart failure and reduced ejection fraction, Circ Cardiovasc Genet, vol.4, pp.163-168, 2011.

S. A. Green, J. Turki, M. Innis, and S. B. Liggett, Amino-terminal polymorphisms of the human beta adrenergic receptor impart distinct agonist-promoted regulatory properties, Biochemistry (Mosc), issue.9

N. Sotoodehnia, D. S. Siscovick, M. Vatta, B. M. Psaty, R. P. Tracy et al., 2-Adrenergic Receptor Genetic Variants and-8

M. C. Gavin, C. Newton-cheh, J. M. Gaziano, N. R. Cook, M. Vandenburgh et al., A Common Variant in the Beta-2 Adrenergic-10

Z. H. Tseng, B. E. Aouizerat, L. Pawlikowska, E. Vittinghoff, F. Lin et al., Common Adrenergic Receptor Polymorphisms Are Not Associated with Risk of Sudden Cardiac Death in Patients with Coronary Artery Disease

W. Bougouin, E. Marijon, E. Puymirat, P. Defaye, D. S. Celermajer et al., Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI, p.22, 2005.

A. Volpi, A. Cavalli, L. Santoro, and E. Negri, Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database, Am J, issue.3, pp.265-71

J. J. Goldberger, A. Basu, and R. Boineau, Risk stratification for sudden cardiac death: a plan for the future, Circulation, vol.129, pp.516-526, 2014.

R. J. Myerburg and M. J. Junttila, Sudden cardiac death caused by coronary heart disease, Circulation, vol.125, pp.1043-1052, 2012.
DOI : 10.1161/circulationaha.111.023846
URL : https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.111.023846

J. A. Hernesniemi, L. Lyytikäinen, and N. Oksala, Predicting sudden cardiac death using common genetic risk variants for coronary artery disease, Eur Heart J, vol.36, pp.1669-1675, 2015.

A. D. Goldberg, C. D. Allis, and E. Bernstein, Epigenetics: a landscape takes shape, Cell, vol.128, pp.635-638, 2007.

A. Bird, Perceptions of epigenetics, Nature, vol.447, pp.396-398, 2007.

R. Jaenisch and A. Bird, Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

, Nat Genet, vol.33, pp.245-254, 2003.

M. W. Deyell, A. D. Krahn, and J. J. Goldberger, Sudden cardiac death risk stratification, Circ Res, vol.116, pp.1907-1918, 2015.

H. Wellens, P. J. Schwartz, and F. W. Lindemans, Risk stratification for sudden cardiac death: current status and challenges for the future, Eur Heart J, vol.35, pp.1642-1651, 2014.

G. Nichol, E. Thomas, C. W. Callaway, J. Hedges, J. L. Powell et al.,

A. , Regional variation in out-of-hospital cardiac arrest incidence and outcome, Resuscitation Outcomes Consortium Investigators, vol.300, issue.12, pp.1423-1431, 2008.

S. S. Chugh, J. Jui, K. Gunson, E. C. Stecker, B. T. John et al.,

J. Mensah-g-&-mcanulty, Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community, J Am Coll Cardiol, vol.44, issue.6, pp.1268-1275, 2004.

P. Borry, C. E. Genetic-testing, and . Guidelines, 158-Riegman PH, Dinjens WN, Oosterhuis JW: Biobanking for interdisciplinary clinical research, European Ethical Paper, vol.3, pp.239-244, 2007.

G. Schmitz, C. Aslanidis, G. Liebisch, and E. Orso, The Danubian Biobank project, Stud Health Technol Inform, vol.134, pp.143-159, 2008.

C. T. Fan, J. C. Lin, and C. H. Lee, Taiwan Biobank: a project aiming to aid Taiwan's transition into a biomedical island, Pharmacogenomics, vol.9, pp.235-246, 2008.

M. Asslaber, P. M. Abuja, K. Stark, J. Eder, H. Gottweis et al., Zat loukal K: The Genome Austria Tissue Bank (GATiB), Pathobiology, vol.74, pp.251-258, 2007.

B. J. Clark, Tissue banking in a regulated environment: does this help the patient? 1. Legislation, regulation and ethics in the UK, Pathobiology, vol.74, pp.218-222, 2007.

S. M. Gibbons, H. H. Helgason, J. Kaye, A. Nomper, and L. Wendel, Lessons from European population genetic databases: comparing the law in Estonia, Iceland, Sweden and the United Kingdom, Eur J Health Law, vol.12, pp.103-133, 2005.

L. Project, Loi fédérale relative à la recherche sur l'être humain (loi relative à la recherche sur l'être humain, LRH), 2006.

, Research Involving Human Biological Materials: Ethical Issues and Policy Guidance

. Rockville, National Bioethics Advisory Com-mission, vol.1, 1999.

, Comité consultatif national d'ethique pour les sciences de la vie et de la santé

, problèmes éthiques posés par les collections de matériel biologique et les données d'information associées: 'biobanques' 'biothèques, 2003.

, Les enjeux éthiques des banques d'information génétique: pour un encadrement démocratique et responsable. 2003

. Council-of-europe, the Committee of Ministers to member states on research on biological materials of human origin, 2006.

E. D. Engelstein and D. P. Zipes, Sudden cardiac death, The Heart, Arteries and Veins, pp.1081-1112, 1998.

R. J. Myerburg and A. Castellanos, Heart Disease: A Textbook of Cardiovascular Medicine, vol.1997, pp.742-779

J. E. Muller, P. G. Kaufmann, R. V. Luepker, M. L. Weisfeldt, P. C. Deedwania et al., for the Mechanisms Precipitating Acute Cardiac Events Participants. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop, Circulation, vol.96, pp.3233-3239, 1997.

K. Willecke, J. Eiberger, J. Degen, D. Eckardt, A. Romualdi et al., Structural and functional diversity of connexin genes in the mouse and human genome, Biological Chemistry, vol.383, pp.725-737, 2002.

P. D. Lampe and A. F. Lau, The effects of connexin phosphorylation on gap junctional communication, Int J Biochem Cell Biol, 2004.

I. L. Thibodeau, J. Xu, Q. Li, G. Liu, K. Lam et al., Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue, Circulation, vol.122, pp.236-244, 2010.

Q. Wu, Y. Wu, L. Zhang, J. Zheng, S. Tang et al., GJA1 gene variations in sudden unexplained nocturnal death syndrome in the

, Chinese Han population, Forensic Sci Int, vol.270, pp.178-182, 2017.

D. W. Van-norstrand, A. Asimaki, C. Rubinos, E. Dolmatova, M. Srinivas et al.,

, Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death, Circulation, vol.125, issue.3, pp.474-81, 2012.

R. Dobrowolski and K. Willecke, Connexin-caused genetic diseases and corresponding mouse models, Antioxid Redox Sign, vol.11, pp.283-296, 2009.

D. Eckardt, S. Kirchhoff, J. S. Kim, J. Degen, M. Theis et al.,

H. V. Rijen, M. D. Schneider, and K. Willecke, Cardiomyocyterestricted deletion of connexin43 during mouse development, J Mol Cell Cardiol, vol.41, pp.963-971, 2006.